In addition, single database analysis showed a positive correlation between RIPK2 expression and different markers that are established to have a role in CRC, mainly Il-6, Il-8, and VEGF (Table 4), which indicates a potential involvement of RIPK2 in driving tumorigenesis. This evidence concerns the gene RIPK2 and colorectal carcinoma.